# Biomarin Pharmaceutical Inc: Form 8-K, filed Sep 30, 2026

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2026-09-30
- Accepted by EDGAR: Sep 30, 2026, 16:15 ET
- Period: 2026-09-24
- Accession: 0001628280-26-063981
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000162828026063981/bmrn-20260924.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000162828026063981/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000162828026063981/bmrn-20260924.htm

Filed Sep 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-063981. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.